About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Long-Acting Injectable HIV PrEP PROs | Clinical Trials | Clareo Health

Back to clinical trial search

Not Yet RecruitingNCT07379658

Long-Acting Injectable HIV PrEP PROs

The goal of this observational study is to learn about the real world effectiveness, patient satisfaction and clinical outcomes of LAI PrEP with lenacapavir (LEN) versus cabotegravir (CAB) through sur...

Lead sponsor: Anupama Raghuram MD•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

NIDI Research Clinic

CONTACT

502-861-4646 [email protected]

Sponsors

Lead Sponsor

Anupama Raghuram MD

Collaborators

Gilead Sciences
University of Louisville

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Adults aged 18 and older
•2. Deemed eligible for HIV PrEP per healthcare provider
•3. Receiving or initiating LAI PrEP, defined as:
•1. Current use of CAB or LEN LAI PrEP at study entry
•2. Initiation of either CAB or LEN LAI PrEP within 30 days of study enrollment
•4. Receiving PrEP services in Louisville, KY
•5. Able to provide informed consent and complete study assessments

Exclusion Criteria

•1. HIV diagnosis prior to enrollment
•2. Currently on oral PrEP with no plans to switch to LAI PrEP
•3. Hypersensitivities to LEN or CAB
•4. Pregnant or planning to become pregnant
•5. PI discretion

Related studies

RECRUITINGPhase 3

A Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-010)

NCT07071623 · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis

Client-Centered Care Coordination for Black Men Who Have Sex With Men

NCT06056544 · HIV Prevention, HIV Pre-exposure Prophylaxis

Vienna HIV Infection Via Sex Study

NCT05326061 · HIV Infections, HIV Pre-Exposure Prophylaxis, and more

COMPLETEDPhase 1

A Study of MK-8527 in Healthy Lactating Female Participants (MK-8527-009)

NCT06580587 · Healthy, HIV Pre-exposure Prophylaxis

Not Yet RecruitingNA

Trauma-informed, Resilience-based Telehealth Intervention for Improving HIV Prevention and HCV Care for Persons Who Inject Drugs in the Deep South (Pilot Testing: Aim3)

NCT06799702 · HIV Pre-exposure Prophylaxis, HEPATITIS C (HCV), and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 30, 2026Terms

Trial snapshot

StatusNOT_YET_RECRUITING

Phase—

Enrollment128

Start dateJan 2026

Last updatedJan 30, 2026

Condition

HIV Pre-exposure Prophylaxis

Locations shown

Norton Healthcare

Louisville, Kentucky

University of Louisville, School of Public Health and Information Sciences

Louisville, Kentucky

University of Louisville, Kent School of Social Work

Louisville, Kentucky

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 30, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions